News Announcement

Glenmark Pharmaceuticals: Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30 2024

GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2024.


दूसरी कैटेगरी